Pembrolizumab with chemotherapy and surgery for treating resectable gastric or gastro-oesophageal junction cancer [ID2696]

  • Discontinued
  • GID-TA10583
Timelines for this appraisal are to be confirmed. Further information regarding the scheduling of this appraisal will be available in due course.